Effects of ketamine and midazolam combination anesthesia on focal cerebral ischemia injury in rats

Journal of Sichuan University (Medical Science)

Volumn 36, Issue 3, 2005, Pages 351-354

  Zhang, Peng Bo ^a   Liu, Yong ^a   Li, Jie ^a   Chen, Xin Lin ^a   Tian, Ying Fang ^a   Sun, Jian Jun ^a   Liu, Jian Xin ^a  

^a MEDICAL SCHOOL OF XI AN JIAOTONG UNIVERSITY   (China)

Author keywords

Focal cerebral ischemia; Ketamine; Midazolam; Rat

Indexed keywords

KETAMINE; MIDAZOLAM;

ANESTHESIA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BRAIN INFARCTION SIZE; BRAIN ISCHEMIA; CELL DENSITY; DRUG EFFECT; FUNCTIONAL DISEASE; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; NEUROPROTECTION; NICK END LABELING; NONHUMAN; RAT; SCORING SYSTEM;

EID: 19744366378     PISSN: 1672173X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Mortier E, Struys M, Herregods L. Therapeutic coma or neuroprotection by anaesthetics. Acta Neurol Belg, 2000;100 (4):225.
2. Chen L, Gong Q, Xiao C, et al. Effects of propofol, midazolam and thiopental sodium on outcome and amino acids accumulation in focal cerebral ischemia-reperfusion in rats. Chin Med J (Engl), 2003;116(2):292.
3. Ito H, Watanabe Y, Isshiki A, et al, Neuroprotective properties of propofol und midazolam, but not pentobarbital, on neuronal damage induced by forebrain ischemia, based on the GABAA receptors. Acta Anaesth Scand, 1999;43(2):153.
4. Porro CA, Cavazzuti M, Giuliani D, et al. Effects of ketamine anesthesia on central rociceptive processing in the rat: A 2-deoxyglucose study. Neuroscience, 2004;125(2):485.
5. Longa EZ, Weinstein FR, Carlson S, et al. Reversible middle cerebral artery occlusion without craniectomy in rats. Stroke, 1989;20(1):84.
6. Wang CX, Yang Y, Yang T, et al. A focal emboliC model of cerebral ischemia in rats: introduction and evaluation. Brain Res. Protoc, 2001;7(2):115.
7. Yang Y, Yang T, Li Q, et al. A new reproducible focal cerebral ischemia model by introduction of polyvinylsiloxane into the middle cerebral artery, a comparison study. J Neurosci Methods, 2002;118(2):199.
8. Sobrado M, Lopez MG, Carceller F, et al. Combined nimodipine and citicoline reduce infarct size, attenuate apoptosis and increase bcl-2 expression after focal cerebral ischemia. Neuroscience, 2003;118(1):107.
9. Zhang RL, Zhang L, Zhang ZG, et al. Migration and differentiation of adult rat subventricular zone progenitor cells transplanted into the adult rat striatum. Neuroscience, 2003; 116(2):373.
10. Reglōdi D, Tamás A, Lengvári I. Examination of sensorimotor performance following middle cerebral artery occlusion in rats. Brain Res Bull, 2003;59(6):459.
11. Gill R, Sibson NR, Hatfield RH, et al. A comparison of the early development of ischaemic damage following permanent middle cerebral artery occlusion in rats as assessed using magnetic resonance imaging and histology. J Cereb Blood Flow Metab, 1995;15(1):1.
12. Engelhard K, Werner C, Eberspacher E, et al. The effect of the alpha 2- agonist ilexmedetomidine and the N-methyl-D-aspartate antagonist S (+)-ketamine on the expression of apoptosis-regulating proteins after incomplete cerebral ischemia and reperfusion in rats , 2003;96(2):524.
13. Proescholdt M, Heimann A, Kempski O. Neuroprotection of S (+) ketamine isomer in global forebrain ischemia. Brain Res, 2001;904(2):245.
14. Lazar RM, Fitzsimmons BF, Masrshall RS, et al. Midazolam challenge reinduces neurological deficits after transient ischemic attack. Stroke, 2003;34(3):794.
15. Zausinger S, Hungerhuber E, Baethmann A, et al. Neurological impairment in rats after transient middle cerebral artery occlusion: a comparative study under various treatment paradigms. Brain Res, 2000;863(1-2):94.